GP1 of Lassa Virus: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
Michal Harel (talk | contribs)
No edit summary
Line 1: Line 1:
<StructureSection load='4zjf' size='340' side='right' caption='4ZJF structure' scene='76/761695/4zjf_chaina/4'>
<StructureSection load='4zjf' size='340' side='right' caption='Receptor binding domain of Lassa Virus (PDB code [[4zjf]])' scene='76/761695/4zjf_chaina/4'>
==Importance==
==Importance==
Lassa virus (LASV), an Old World (OW) [http://en.wikipedia.org/wiki/Arenavirus arenavirus], is a notorious disease-causing agent primarily in West Africa that is able to spread from rodents to humans. This deadly pathogen causes severe viral hemorrhagic fevers and significant mortality. So far, there are no available vaccines for LASV, and only one successful vaccine against another virus found in the ''Arenaviridae'' family: Junin virus<ref name="PMID: 9466512">PMID: 9466512 </ref>. Structural data at atomic resolution for viral proteins are laying the foundation for better understanding both the biology behind viral proteins and ways to combat against them. Determining the structure of the complete trimeric glycoprotein complex (GPC), composed of GP1, GP2, and SSP (stable signal peptide), will pave the path towards a future discovery of novel antiviral drugs. This is the first representative structure for OW arenaviruses. This structure reveals the overall architecture of GP1 domains from OW arenaviruses and important information relating to the mechanisms for pH switching and the binding of LASV to [[LAMP1]] (Lysosome-associated membrane glycoprotein), a recently identified host receptor that is critical for successful infection. In addition, structural analysis suggests two novel immune evasion mechanisms that LASV may utilize to escape antibody-based immune response.
Lassa virus (LASV), an Old World (OW) [http://en.wikipedia.org/wiki/Arenavirus arenavirus], is a notorious disease-causing agent primarily in West Africa that is able to spread from rodents to humans. This deadly pathogen causes severe viral hemorrhagic fevers and significant mortality. So far, there are no available vaccines for LASV, and only one successful vaccine against another virus found in the ''Arenaviridae'' family: Junin virus<ref name="PMID: 9466512">PMID: 9466512 </ref>. Structural data at atomic resolution for viral proteins are laying the foundation for better understanding both the biology behind viral proteins and ways to combat against them. Determining the structure of the complete trimeric glycoprotein complex (GPC), composed of GP1, GP2, and SSP (stable signal peptide), will pave the path towards a future discovery of novel antiviral drugs. This is the first representative structure for OW arenaviruses. This structure reveals the overall architecture of GP1 domains from OW arenaviruses and important information relating to the mechanisms for pH switching and the binding of LASV to [[LAMP1]] (Lysosome-associated membrane glycoprotein), a recently identified host receptor that is critical for successful infection. In addition, structural analysis suggests two novel immune evasion mechanisms that LASV may utilize to escape antibody-based immune response.

Revision as of 11:12, 7 January 2018

Receptor binding domain of Lassa Virus (PDB code 4zjf)

Drag the structure with the mouse to rotate

References

Proteopedia Page Contributors and Editors (what is this?)

Rebecca Holstein, Michal Harel